Get the Stockscreener App
1.17
2.50%
-0.03
After Hours:
1.17
Oncolytics Biotech Inc stock is traded at $1.17, with a volume of 999.92K.
It is down -2.50% in the last 24 hours and down -8.59% over the past month.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
See More
Previous Close:
$1.20
Open:
$1.16
24h Volume:
999.92K
Relative Volume:
0.97
Market Cap:
$117.42M
Revenue:
-
Net Income/Loss:
$-20.31M
P/E Ratio:
-4.4234
EPS:
-0.2645
Net Cash Flow:
$-21.07M
1W Performance:
-13.97%
1M Performance:
-8.59%
6M Performance:
+87.83%
1Y Performance:
-6.40%
1-Day Range:
$1.14
$1.22
1-Week Range:
$1.14
$1.39
52-Week Range:
$0.3258
$1.51
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Compare ONCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.17 | 121.50M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Initiated | Lake Street | Buy |
| Oct-06-22 | Initiated | Maxim Group | Buy |
| Feb-17-21 | Initiated | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Stock (ONCY) Latest News
Published on: 2025-10-13 08:31:55 - newser.com
Relative strength of Oncolytics Biotech Inc. in sector analysis2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Is Oncolytics Biotech Inc. stock overvalued by current metricsMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com
Published on: 2025-10-13 07:15:35 - newser.com
Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy - TipRanks
Understanding Oncolytics Biotech Inc.’s price movementMarket Growth Summary & Weekly Breakout Watchlists - newser.com
Oncolytics Biotech's (ONCY) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat
Is Oncolytics Biotech Inc. reversing from oversold territoryGold Moves & Real-Time Stock Entry Alerts - newser.com
Oncolytics Biotech (NASDAQ:ONCY) Trading Down 3.1%Should You Sell? - MarketBeat
Oncolytic Virus Therapy Market Size to Hit USD 11.13 Billion by 2034 - Precedence Research
Volatility clustering patterns for Oncolytics Biotech Inc.Market Sentiment Review & Weekly Consistent Profit Watchlists - newser.com
Is Oncolytics Biotech Inc. forming a bottoming baseJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com
Is Oncolytics Biotech Inc. stock positioned for long term growthTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Published on: 2025-10-03 07:12:20 - newser.com
Using RSI to spot recovery in Oncolytics Biotech Inc.July 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Candlestick signals on Oncolytics Biotech Inc. stock todayMarket Movement Recap & Community Driven Trade Alerts - newser.com
Oncolytics Biotech unveils design for pancreatic cancer registration trial By Investing.com - Investing.com Canada
Is Oncolytics Biotech Inc a good long term investmentTrading Volume Trends & Access Our Free Weekly Investment Letter - earlytimes.in
What Makes Vision Corporation Limited Stand Out Among CompetitorsDouble Top/Bottom Patterns & Big Gains Small Budget - earlytimes.in
Stocks in play: Oncolytics Biotech Inc. - The Globe and Mail
Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design - TipRanks
Oncolytics Biotech announces update for potential first-line pancreatic cancer registration study - MarketScreener
Oncolytics Biotech® Announces Update for Potential First-Line Pa - GuruFocus
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
Oncolytics Biotech unveils design for pancreatic cancer registration trial - Investing.com India
How Oncolytics Biotech Inc. stock trades before earningsLong Setup & Accurate Entry/Exit Alerts - newser.com
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study - PR Newswire
What analysts say about Oncolytics Biotech Inc stockMean Reversion Trades & Free Daily Top Stock Picks for All Investors - earlytimes.in
What drives Oncolytics Biotech Inc stock priceReal-Time Stock Alerts & See Risk Factors Before Making Any Move - earlytimes.in
Oncolytics Biotech Inc Stock Analysis and ForecastStock Price Targets & High Return Investment Plans - earlytimes.in
Oncolytics Biotech Inc. stock trend outlook and recovery pathJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Published on: 2025-09-26 15:22:59 - newser.com
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone - Investing News Network
Q3 EPS Estimates for Oncolytics Biotech Cut by HC Wainwright - MarketBeat
Applying chart zones and confluence areas to Oncolytics Biotech Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Oncolytics Biotech Inc. (NASDAQ:ONCY) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Oncolytics Biotech (NASDAQ:ONCY) Stock Price Down 3.1%Time to Sell? - MarketBeat
Meme Stocks: Is Oncolytics Biotech Inc a top pick in the sector2025 Performance Recap & Free Community Consensus Stock Picks - خودرو بانک
Breakouts Watch: Will Tyson Foods Inc. outperform tech stocksCEO Change & Technical Entry and Exit Alerts - khodrobank.com
Wall Street Recap: What are Oncolytics Biotech Incs earnings expectationsEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Oncolytics Biotech Inc Stock (ONCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):